<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="doi: 10.1038/s41531-020-00123-0 : Perspective COVID-19 and possible links with Parkinsonâ€™s" exact="disease" post="and parkinsonism: from bench to bedside http://orcid.org/0000-0001-7632-0439SulzerDavid1http://orcid.org/0000-0003-1040-2807AntoniniAngelo2LetaValentina34NordvigAnna5SmeyneRichard J.6GoldmanJames E.7Al-DalahmahOsama7ZeccaLuigi8SetteAlessandro910http://orcid.org/0000-0001-7927-9208BubaccoLuigi11http://orcid.org/0000-0001-8333-4804MeucciOlimpia121314MoroElena151617http://orcid.org/0000-0002-7054-2812HarmsAshley"/>
 <result pre="E.7Al-DalahmahOsama7ZeccaLuigi8SetteAlessandro910http://orcid.org/0000-0001-7927-9208BubaccoLuigi11http://orcid.org/0000-0001-8333-4804MeucciOlimpia121314MoroElena151617http://orcid.org/0000-0002-7054-2812HarmsAshley S.18XuYaqian19FahnStanley5http://orcid.org/0000-0003-2815-0505Ray ChaudhuriK.ray.chaudhuri@kcl.ac.uk34[1], [2], grid.5608.b0000 0004 1757 3470Department of Neuroscience," exact="Parkinson" post="and Movement Disorders Unit, University of Padua, [3], grid.13097.3c0000"/>
 <result pre="[2], grid.5608.b0000 0004 1757 3470Department of Neuroscience, Parkinson and Movement" exact="Disorders" post="Unit, University of Padua, [3], grid.13097.3c0000 0001 2322 6764Kingâ€™s"/>
 <result pre="of Neuroimmunology and CNS Therapeutics, Institute of Molecular Medicine and" exact="Infectious" post="Diseases, Drexel University College of Medicine, [14], grid.166341.70000 0001"/>
 <result pre="[17], grid.450307.5Grenoble Alpes University, [18], grid.265892.20000000106344187Department of Neurology, Center for" exact="Neurodegeneration" post="and Experimental Therapeutics, University of Alabama at Birmingham, [19],"/>
 <result pre="discusses insights from basic science and clinical perspectives on coronavirus" exact="disease" post="2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the"/>
 <result pre="basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe" exact="acute" post="respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a"/>
 <result pre="science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute" exact="respiratory" post="syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular"/>
 <result pre="perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)" exact="infection" post="in the brain, with a particular focus on Parkinsonâ€™s"/>
 <result pre="not answered the central issue of whether the virus enters" exact="central nervous system" post="neurons, astrocytes or microglia, and the brain vascular cell"/>
 <result pre="enters central nervous system neurons, astrocytes or microglia, and the" exact="brain" post="vascular cell types that express virus have not yet"/>
 <result pre="central nervous system neurons, astrocytes or microglia, and the brain" exact="vascular" post="cell types that express virus have not yet been"/>
 <result pre="been identified. Currently, there is no clear evidence for human" exact="neuronal" post="or astrocyte expression of angiotensin-converting enzyme 2 (ACE2), the"/>
 <result pre="expression of angiotensin-converting enzyme 2 (ACE2), the major receptor for" exact="viral" post="entry, but ACE2 expression may be activated by inflammation,"/>
 <result pre="is important. In contrast to the 1918 influenza pandemic and" exact="avian flu," post="reports of encephalopathy in COVID-19 have been slow to"/>
 <result pre="to the 1918 influenza pandemic and avian flu, reports of" exact="encephalopathy" post="in COVID-19 have been slow to emerge, and there"/>
 <result pre="emerge, and there are so far no documented reports of" exact="parkinsonism" post="apart from a single case report. We recommend consensus"/>
 <result pre="a role for the virus in causing or exacerbating Parkinsonâ€™s" exact="disease" post="appears unlikely at this time, aggravation of specific motor"/>
 <result pre="research Translational research Introduction Over the past twenty years, novel" exact="viral" post="epidemics, including influenza, severe acute respiratory syndrome (SARS) and"/>
 <result pre="the past twenty years, novel viral epidemics, including influenza, severe" exact="acute" post="respiratory syndrome (SARS) and Middle Eastern respiratory syndrome (MERS),"/>
 <result pre="past twenty years, novel viral epidemics, including influenza, severe acute" exact="respiratory" post="syndrome (SARS) and Middle Eastern respiratory syndrome (MERS), have"/>
 <result pre="twenty years, novel viral epidemics, including influenza, severe acute respiratory" exact="syndrome" post="(SARS) and Middle Eastern respiratory syndrome (MERS), have appeared,"/>
 <result pre="including influenza, severe acute respiratory syndrome (SARS) and Middle Eastern" exact="respiratory" post="syndrome (MERS), have appeared, likely through zoonosis1â€&quot;6. There are"/>
 <result pre="influenza, severe acute respiratory syndrome (SARS) and Middle Eastern respiratory" exact="syndrome" post="(MERS), have appeared, likely through zoonosis1â€&quot;6. There are few,"/>
 <result pre="family members SARS-CoV and MERS-CoV, SARS-CoV-2 initially presents as a" exact="respiratory" post="illness, characterized by cough, dyspnea, fever, and other upper"/>
 <result pre="a respiratory illness, characterized by cough, dyspnea, fever, and other" exact="upper" post="and lower respiratory systems manifestations11. However, COVID-19 is associated"/>
 <result pre="illness, characterized by cough, dyspnea, fever, and other upper and" exact="lower" post="respiratory systems manifestations11. However, COVID-19 is associated with a"/>
 <result pre="characterized by cough, dyspnea, fever, and other upper and lower" exact="respiratory" post="systems manifestations11. However, COVID-19 is associated with a variety"/>
 <result pre="recovered from COVID-19 have developed T cells that recognize specific" exact="viral" post="epitopes, including the S protein12. The extraordinarily wide range"/>
 <result pre="of T cells previously developed in response to prior coronavirus" exact="infections" post="that cross-react with SARS-CoV-2, and it is remarkable that"/>
 <result pre="in different symptoms13. Epidemiological and public health studies indicate that" exact="infection" post="with the SARS-CoV-2 affects all demographics, but has grave"/>
 <result pre="disproportionate manner (https://www.england.nhs.uk/coronavirus/workforce/addressing-impact-of-covid-19-on-bame-staff-in-the-nhs/). This is not always the case for" exact="viral" post="disorders, as some, like polio, are typically more dangerous"/>
 <result pre="typically more dangerous for the young15. The impression that SARS-CoV-2" exact="infection" post="was particularly pathogenic in older frail subjects has been"/>
 <result pre="the cytokine storm is more easily triggered in patients with" exact="chronic" post="inflammation, such as those with diabetes, obesity, and cardiac"/>
 <result pre="remains unclear, although role of comorbidities such as diabetes, hypertension," exact="and obesity" post="as well as social deprivation are implicated (https://www.england.nhs.uk/coronavirus/workforce/addressing-impact-of-covid-19-on-bame-staff-in-the-nhs/). While"/>
 <result pre="unclear, although role of comorbidities such as diabetes, hypertension, and" exact="obesity" post="as well as social deprivation are implicated (https://www.england.nhs.uk/coronavirus/workforce/addressing-impact-of-covid-19-on-bame-staff-in-the-nhs/). While"/>
 <result pre="need to be hospitalized and sometimes intubated due to severe" exact="respiratory" post="distress21. Other serious consequences of COVID-19 include acute kidney"/>
 <result pre="to severe respiratory distress21. Other serious consequences of COVID-19 include" exact="acute" post="kidney injury, a coagulopathy similar to disseminated intravascular coagulation22,"/>
 <result pre="severe respiratory distress21. Other serious consequences of COVID-19 include acute" exact="kidney injury," post="a coagulopathy similar to disseminated intravascular coagulation22, thrombosis23, and"/>
 <result pre="Other serious consequences of COVID-19 include acute kidney injury, a" exact="coagulopathy" post="similar to disseminated intravascular coagulation22, thrombosis23, and a newly"/>
 <result pre="to disseminated intravascular coagulation22, thrombosis23, and a newly recognized post-infection" exact="syndrome" post="in children, known as multi-system inflammatory syndrome in children"/>
 <result pre="newly recognized post-infection syndrome in children, known as multi-system inflammatory" exact="syndrome" post="in children potentially associated with COVID-1924. The sequelae of"/>
 <result pre="(fatigue, headache, confusion, stroke33, dizziness, syncope34, seizure, anorexia, and insomnia)35â€&quot;38," exact="peripheral" post="(anosmia, ageusia, myoclonus39, neuropathic pain, and myalgias)26,35,40, combined central-peripheral"/>
 <result pre="including diarrhea, may be related to the expression of the" exact="viral" post="receptor ACE2 and a serine protease, transmembrane serine protease"/>
 <result pre="spread via the olfactory, lingual, and glossopharyngeal nerves (Fig. 1)," exact="secondary" post="to a respiratory route of infection. Hyposmia is now"/>
 <result pre="olfactory, lingual, and glossopharyngeal nerves (Fig. 1), secondary to a" exact="respiratory" post="route of infection. Hyposmia is now officially recognized as"/>
 <result pre="be a sign in â€œasymptomaticâ€� carriers who may not have" exact="upper" post="respiratory tract symptoms. Fig. 1 Possible entry routes for"/>
 <result pre="a sign in â€œasymptomaticâ€� carriers who may not have upper" exact="respiratory" post="tract symptoms. Fig. 1 Possible entry routes for SARS-CoV-2"/>
 <result pre="tract symptoms. Fig. 1 Possible entry routes for SARS-CoV-2 into" exact="central nervous system" post="and potential intracellular consequences. There is evidence for SARS-CoV-2"/>
 <result pre="vasculature in the brain, but little evidence for SARS-CoV-2 in" exact="brain" post="parenchyma at this time: this issue will become clearer"/>
 <result pre="in neurons or astrocytes, there may be multiple consequences for" exact="brain" post="cells, in part through intracellular responses to inflammation that"/>
 <result pre="hospital suggested emergence of specific neurological presentations, including encephalopathies, inflammatory" exact="central nervous system" post="syndromes, ischemic strokes, and peripheral neurological disorders, although parkinsonism"/>
 <result pre="including encephalopathies, inflammatory central nervous system syndromes, ischemic strokes, and" exact="peripheral" post="neurological disorders, although parkinsonism and rates of hyposmia or"/>
 <result pre="nervous system syndromes, ischemic strokes, and peripheral neurological disorders, although" exact="parkinsonism" post="and rates of hyposmia or ageusia were not reported44."/>
 <result pre="have previously flagged concerns regarding COVID-19 in people with Parkinsonâ€™s" exact="disease" post="(PD), especially for older and frail subjects with advanced"/>
 <result pre="who may be particularly vulnerable45,46. Historical aspects of viruses and" exact="parkinsonism" post="It is remarkable that a relationship between the presence"/>
 <result pre="OC43 and 229E, in the cerebrospinal fluid (CSF) and Parkinsonâ€™s" exact="disease" post="was reported nearly twenty years prior to the current"/>
 <result pre="including in children49,50. Medical history provides observations supporting links between" exact="viral" post="infections and parkinsonism51. The best known example is the"/>
 <result pre="in children49,50. Medical history provides observations supporting links between viral" exact="infections" post="and parkinsonism51. The best known example is the post-encephalitic"/>
 <result pre="infections and parkinsonism51. The best known example is the post-encephalitic" exact="parkinsonism" post="observed during the encephalitic lethargica outbreak that overlapped with"/>
 <result pre="pandemic in 191852. However, after 100 years, the cause of" exact="encephalitis" post="lethargica still remains a mystery53. While a causal role"/>
 <result pre="of influenza A H1N1 virus in the development of post-encephalitic" exact="parkinsonism" post="is not confirmed52, an association between influenza A virus"/>
 <result pre="post-encephalitic parkinsonism is not confirmed52, an association between influenza A" exact="virus infection" post="and development of transient parkinsonism is reported54. Notably, the"/>
 <result pre="parkinsonism is not confirmed52, an association between influenza A virus" exact="infection" post="and development of transient parkinsonism is reported54. Notably, the"/>
 <result pre="an association between influenza A virus infection and development of" exact="transient" post="parkinsonism is reported54. Notably, the avian flu resulted in"/>
 <result pre="association between influenza A virus infection and development of transient" exact="parkinsonism" post="is reported54. Notably, the avian flu resulted in parkinsonism"/>
 <result pre="infection and development of transient parkinsonism is reported54. Notably, the" exact="avian flu" post="resulted in parkinsonism in many survivors55. Other viral infections"/>
 <result pre="transient parkinsonism is reported54. Notably, the avian flu resulted in" exact="parkinsonism" post="in many survivors55. Other viral infections have been associated"/>
 <result pre="the avian flu resulted in parkinsonism in many survivors55. Other" exact="viral" post="infections have been associated with the development of transient"/>
 <result pre="avian flu resulted in parkinsonism in many survivors55. Other viral" exact="infections" post="have been associated with the development of transient or,"/>
 <result pre="Other viral infections have been associated with the development of" exact="transient" post="or, more rarely, permanent parkinsonism, including Epstein-Barr, Japanese encephalitis,"/>
 <result pre="development of transient or, more rarely, permanent parkinsonism, including Epstein-Barr," exact="Japanese encephalitis," post="Coxsackie, West Nile, Western equine encephalomyelitis, and human immunodeficiency"/>
 <result pre="rarely, permanent parkinsonism, including Epstein-Barr, Japanese encephalitis, Coxsackie, West Nile," exact="Western equine encephalomyelitis," post="and human immunodeficiency virus, mostly due to induction of"/>
 <result pre="Japanese encephalitis, Coxsackie, West Nile, Western equine encephalomyelitis, and human" exact="immunodeficiency" post="virus, mostly due to induction of neuroinflammation and/or hypoxic"/>
 <result pre="encephalomyelitis, and human immunodeficiency virus, mostly due to induction of" exact="neuroinflammation" post="and/or hypoxic brain injury with structural/functional damage within the"/>
 <result pre="immunodeficiency virus, mostly due to induction of neuroinflammation and/or hypoxic" exact="brain" post="injury with structural/functional damage within the basal ganglia51,54 (Table"/>
 <result pre="ganglia51,54 (Table 1). In addition, debated evidence suggests that previous" exact="infection" post="with herpes simplex 1, Epstein-Barr, varicella zoster, hepatitis C,"/>
 <result pre="1). In addition, debated evidence suggests that previous infection with" exact="herpes" post="simplex 1, Epstein-Barr, varicella zoster, hepatitis C, and influenza"/>
 <result pre="that previous infection with herpes simplex 1, Epstein-Barr, varicella zoster," exact="hepatitis C," post="and influenza A virus can increase the risk of"/>
 <result pre="in PD pathogenesis, the role of â€œenvironmentalâ€� factors acting as" exact="peripheral" post="triggers of the neurodegenerative process in susceptible individuals has"/>
 <result pre="involved in the pathogenesis of viral-induced parkinsonism. Mechanism Type of" exact="neuronal" post="damage Virus tropism for basal ganglia, replication and subsequent"/>
 <result pre="neuronal damage Virus tropism for basal ganglia, replication and subsequent" exact="neuronal" post="lysis Direct Microglia activation and release of pro-inflammatory factors"/>
 <result pre="factors and T cell response Indirect Hypercytokinemia and loss of" exact="vascular" post="integrity Indirect Hypoxic brain injury Indirect SARS-CoV-2 receptors and"/>
 <result pre="response Indirect Hypercytokinemia and loss of vascular integrity Indirect Hypoxic" exact="brain" post="injury Indirect SARS-CoV-2 receptors and cellular uptake There is"/>
 <result pre="point of attachment to plasma membrane proteins which act as" exact="viral" post="receptors for cellular infection. The S protein is thought"/>
 <result pre="of the virus, leading ultimately to RNA translation, transcription, and" exact="viral" post="replication, will not be reviewed here. At this time"/>
 <result pre="including SARS-CoV62,63. The distribution of ACE2 throughout the body and" exact="brain" post="is discussed below. Recent in-silico studies64,65 propose that, in"/>
 <result pre="types, including neurons, and are very highly expressed in the" exact="upper" post="respiratory tract. Additional observations that may test the predictions"/>
 <result pre="including neurons, and are very highly expressed in the upper" exact="respiratory" post="tract. Additional observations that may test the predictions from"/>
 <result pre="clinical trial of DAS181 (https://clinicaltrials.gov/ct2/show/NCT04324489), a drug designed to block" exact="viral" post="access by cleaving sialic acid; (3) that the shedding"/>
 <result pre="cleaving sialic acid; (3) that the shedding pattern of SARS-CoV-2" exact="infection" post="is different from that of SARS-CoV and more similar"/>
 <result pre="knowledge, while links between sialic acid and neurotropism for mouse" exact="hepatitis" post="virus68 and adenoviruses69 have been suggested, there are no"/>
 <result pre="patients with SARS, however to have suggested the presence of" exact="viral" post="particles in central nervous system (CNS) tissue71,72. A recent"/>
 <result pre="however to have suggested the presence of viral particles in" exact="central nervous system" post="(CNS) tissue71,72. A recent publication examining the localization of"/>
 <result pre="and the signals may not have been present within the" exact="brain" post="parenchyma73. A second study similarly reports detectable SARS-CoV-2 RNA"/>
 <result pre="study similarly reports detectable SARS-CoV-2 RNA in four of 12" exact="brain" post="samples, although again the signal may not have been"/>
 <result pre="samples, although again the signal may not have been from" exact="brain" post="parenchymal cells74. While there is, at this time, little"/>
 <result pre="is, at this time, little evidence that SARS-CoV-2 enters the" exact="brain" post="parenchyma, there are multiple means by which the virus"/>
 <result pre="and brainstem; we note, however, that these mice over-express the" exact="viral" post="receptors, and these reports do not model normal infection"/>
 <result pre="the viral receptors, and these reports do not model normal" exact="infection" post="routes. Trans-synaptic transfer has been documented in rat and"/>
 <result pre="rat and pig for other types of coronavirus, including hemagglutinating" exact="encephalomyelitis" post="virus (HEV)79â€&quot;81 and avian infectious bronchitis virus (IBV, also"/>
 <result pre="types of coronavirus, including hemagglutinating encephalomyelitis virus (HEV)79â€&quot;81 and avian" exact="infectious" post="bronchitis virus (IBV, also known as avian coronavirus)82, in"/>
 <result pre="of coronavirus, including hemagglutinating encephalomyelitis virus (HEV)79â€&quot;81 and avian infectious" exact="bronchitis" post="virus (IBV, also known as avian coronavirus)82, in both"/>
 <result pre="SARS-CoV were not detected in non-neuronal cells in human post-mortem" exact="brain" post="tissue71,72. One potential mechanism for SARS-CoV-2 RNA presence within"/>
 <result pre="potential mechanism for SARS-CoV-2 RNA presence within the CNS is" exact="blood-brain barrier" post="(BBB) breakdown due to the cytokine storm associated with"/>
 <result pre="barrier (BBB) breakdown due to the cytokine storm associated with" exact="peripheral" post="viral infection. It is well established that pro-inflammatory cytokines"/>
 <result pre="(BBB) breakdown due to the cytokine storm associated with peripheral" exact="viral infection." post="It is well established that pro-inflammatory cytokines associated with"/>
 <result pre="well established that pro-inflammatory cytokines associated with inflammation and/or SARS-CoV-2" exact="viral infection," post="such as tumor necrosis factor (TNF) and interleukin 1"/>
 <result pre="cytokines associated with inflammation and/or SARS-CoV-2 viral infection, such as" exact="tumor" post="necrosis factor (TNF) and interleukin 1 beta (IL-1beta), mediate"/>
 <result pre="in neurodegenerative diseases allowing for infiltration of immune cells and" exact="viral" post="particles, or transient, resulting in encephalitis84,85. We note that"/>
 <result pre="(RT-PCR). This suggests that even with the presence of high" exact="viral" post="load in the blood stream and severe inflammation, COVID-19"/>
 <result pre="to exhibit direct neurotropism, but rather appears to cause inflammatory-mediated" exact="brain" post="responses86. Presence of SARS-CoV-2 receptors in the brain ACE2"/>
 <result pre="cause inflammatory-mediated brain responses86. Presence of SARS-CoV-2 receptors in the" exact="brain" post="ACE2 was identified in 2000 as a novel carboxypeptidase"/>
 <result pre="signals including in macrophages91. Evidence supporting ACE2 expression in human" exact="brain" post="parenchyma, however, remains poor, in contrast to clear expression"/>
 <result pre="however, remains poor, in contrast to clear expression in the" exact="brain" post="vessels92. There is an extensive literature indicating that ACE2"/>
 <result pre="human CNS neurons is not well established, nor are specific" exact="brain" post="regions or neuronal, astrocyte, microglial, immune or vascular cell"/>
 <result pre="are specific brain regions or neuronal, astrocyte, microglial, immune or" exact="vascular" post="cell types well characterized. The ACE2 promoter harbors five"/>
 <result pre="well characterized. The ACE2 promoter harbors five hypoxia-responsive elements, and" exact="hypoxia" post="may upregulate ACE2 via HIF1A-independent mechanisms98, but it has"/>
 <result pre="HIF1A-independent mechanisms98, but it has not yet been determined if" exact="hypoxia" post="upregulates ACE2 in brain cells. It is very important"/>
 <result pre="has not yet been determined if hypoxia upregulates ACE2 in" exact="brain" post="cells. It is very important to compare the presence"/>
 <result pre="cells. It is very important to compare the presence of" exact="brain" post="ACE2, and perhaps of CD209L and molecules with sialic"/>
 <result pre="inflammatory responses90, and may be regulated by excitotoxicity100. The Human" exact="Protein" post="Atlas reports that ACE2 is not detected in normal"/>
 <result pre="in normal human brain, but indicates low amounts in mouse" exact="brain" post="(https://www.proteinatlas.org/ENSG00000130234-ACE2/tissue). As mentioned, an immunocytochemistry study of human brain"/>
 <result pre="mouse brain (https://www.proteinatlas.org/ENSG00000130234-ACE2/tissue). As mentioned, an immunocytochemistry study of human" exact="brain" post="tissue indicated that ACE2 is present in non-neuronal cells"/>
 <result pre="ACE2 is present in non-neuronal cells of vasculature in human" exact="brain" post="tissue92, although that study did not define the precise"/>
 <result pre="analysis suggests differential levels of ACE2 mRNA in different mouse" exact="brain" post="regions101. Another preprint features a meta-analysis of single-cell and"/>
 <result pre="inflammation, and endoplasmic reticulum stress, it is possible that SARS-CoV-2" exact="infection" post="may prompt protein misfolding and aggregation (Fig. 1)103â€&quot;105. Of"/>
 <result pre="alpha-synuclein, plays a role in the innate immune response to" exact="viral" post="infections106,107. It will be important to follow up and"/>
 <result pre="neurodegenerative process or, alternatively, hyposmia may be a sign of" exact="peripheral" post="inflammatory involvement of the olfactory mucosa. It is, therefore,"/>
 <result pre="cases where recovery is associated with sustained hyposmia after the" exact="acute" post="illness of COVID-19 has subsided. COVID-19 and the possibility"/>
 <result pre="to enter the CNS through the nasal cavity with subsequent" exact="neuronal" post="death77,78, as shown in animal studies. Hyposmia is well"/>
 <result pre="ganglia lesions may occur in the context of a thromboembolic" exact="encephalopathy" post="in COVID-19116. The presence of higher levels of antibodies"/>
 <result pre="patients compared to healthy controls suggests a possible involvement of" exact="viral infection" post="in the pathogenesis of PD47. There are reports that"/>
 <result pre="compared to healthy controls suggests a possible involvement of viral" exact="infection" post="in the pathogenesis of PD47. There are reports that"/>
 <result pre="case report of a patient who developed myoclonus and an" exact="acute" post="but spontaneously reversible hypokinetic rigid syndrome, with DaTscan showing"/>
 <result pre="lead to their infiltration from the periphery that result in" exact="brain" post="cell damage. Such cells may include activated T cells"/>
 <result pre="T cells and microglia that may kill neurons122â€&quot;124, astrocytes, and" exact="vascular" post="cell types. This may occur through the selection of"/>
 <result pre="selection of cells that specifically recognize presented antigens from the" exact="infection" post="or previous infections, or via a general activation of"/>
 <result pre="from alpha-synuclein which are implicated in PD, Lewy Body dementias," exact="multiple system atrophy," post="and multiple sclerosis125,126. High levels of pro-inflammatory cytokines, such"/>
 <result pre="significant observational literature discussed above that suggests a relationship between" exact="viral infection" post="and PD51, a number of preclinical studies have directly"/>
 <result pre="observational literature discussed above that suggests a relationship between viral" exact="infection" post="and PD51, a number of preclinical studies have directly"/>
 <result pre="mice exhibited ataxia, tremor, and bradykinesia128 as well as a" exact="transient" post="but significant loss of dopaminergic neuron phenotype, an early"/>
 <result pre="to contribute to development of PD. The idea that a" exact="peripheral" post="cytokine storm from non-neurotropic viruses can induce encephalitis has"/>
 <result pre="that a peripheral cytokine storm from non-neurotropic viruses can induce" exact="encephalitis" post="has been suggested for many other viral infections, including"/>
 <result pre="viruses can induce encephalitis has been suggested for many other" exact="viral" post="infections, including the 1918 Spanish influenza (Type A H1N1)131,132"/>
 <result pre="the 1918 Spanish influenza (Type A H1N1)131,132 as well as" exact="respiratory" post="syncytial virus133. Notably, the pandemic 2009 H1N1 (CA/09) influenza"/>
 <result pre="(CA/09) influenza virus does not infect neurons in the central," exact="peripheral" post="or enteric nervous systems, but can nevertheless induce a"/>
 <result pre="neuroinflammatory mechanism of this sort might increase the risk of" exact="parkinsonism" post="is that mice infected with the 2009 H1N1 virus,"/>
 <result pre="is that mice infected with the 2009 H1N1 virus, after" exact="complete" post="resolution of peripheral infection, displayed a higher level of"/>
 <result pre="infected with the 2009 H1N1 virus, after complete resolution of" exact="peripheral" post="infection, displayed a higher level of SNpc DA neuron"/>
 <result pre="microgliosis and increase in inflammatory cytokines and chemokines in the" exact="brain" post="were not due to invasion of CD4+/CD8+ T-cells from"/>
 <result pre="T-cells from the periphery, suggesting that inflammatory cytokines released during" exact="peripheral" post="infection passed through the blood-brain barrier135 and indirectly activated"/>
 <result pre="from the periphery, suggesting that inflammatory cytokines released during peripheral" exact="infection" post="passed through the blood-brain barrier135 and indirectly activated microglia,"/>
 <result pre="interleukin 10 (IL-10)136, while prophylactic treatment with oseltamivir (Tamiflu) decreased" exact="disease" post="severity of influenza in both human and mouse models,"/>
 <result pre="The need for detailed autopsy studies As deaths from SARS-CoV-2" exact="infection" post="continue, autopsy studies will play a key role in"/>
 <result pre="increased precautions taken at the time of autopsy, relatively few" exact="brain" post="autopsies are being performed. The U.S. Centers for Disease"/>
 <result pre="few brain autopsies are being performed. The U.S. Centers for" exact="Disease" post="Control has issued guidance on autopsies for confirmed SARS-CoV-2"/>
 <result pre="that generate aerosols, such as those used to remove the" exact="brain" post="(https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html#biosafety). Most studies thus far lack neuropathologic characterization altogether138â€&quot;142,"/>
 <result pre="care facilities, where a large subset of patients suffering from" exact="dementia" post="reside, are less likely to result in autopsies. We"/>
 <result pre="thus expect a delay in understanding whether and how SARS-CoV-2" exact="infection" post="specifically alters neuropathology, including in PD. Of the available"/>
 <result pre="one case series of ten autopsies documented no signs of" exact="encephalitis" post="or CNS vasculitis, although the extent of neuroanatomic sampling"/>
 <result pre="of COVID-19 autopsy findings included four brains that exhibited no" exact="encephalitis" post="or neuronal necrosis, but mild hypoxemic changes in three"/>
 <result pre="autopsy findings included four brains that exhibited no encephalitis or" exact="neuronal" post="necrosis, but mild hypoxemic changes in three of the"/>
 <result pre="alterations, the extent of involvement of the CNS in SARS-CoV-2" exact="infection" post="cannot be inferred from only 14 brains. To establish"/>
 <result pre="be inferred from only 14 brains. To establish how SARS-CoV-2" exact="infection" post="affects the CNS, the field will require detailed neuropathologic"/>
 <result pre="will require detailed neuropathologic studies with thorough sampling of specific" exact="brain" post="regions. At the Columbia University Medical Center, a current"/>
 <result pre="current approach involves sampling of multiple neuroanatomic regions, including the" exact="cerebral" post="cortex, watershed areas, white matter, olfactory system, hippocampus, amygdala,"/>
 <result pre="encephalitis, and vasculitis. The clinical perspective Clinical implications of SARS-CoV-2" exact="infection" post="on PD are largely speculative apart from two case"/>
 <result pre="during mild to moderate COVID-19 illness, independent of age and" exact="disease" post="duration144, in line with an original case report series"/>
 <result pre="robust evidence that having PD imparts an increased risk for" exact="susceptibility to" post="COVID-19 or that COVID-19 confers a greater risk of"/>
 <result pre="advanced therapies and one case report of development of an" exact="acute" post="hypokinetic syndrome with hyposmia post COVID-19. Broadly, the clinical"/>
 <result pre="and one case report of development of an acute hypokinetic" exact="syndrome" post="with hyposmia post COVID-19. Broadly, the clinical impact of"/>
 <result pre="multiple avenues: Development of COVID-19-related symptoms, particularly high fever, severe" exact="respiratory" post="distress, coagulopathy-related syndrome, fatigue, myalgias, and related impaired stress"/>
 <result pre="related impaired stress mechanisms. Worsening of pre-existing dyspnea due to" exact="respiratory" post="distress; dyspnea may exist in up to 39% of"/>
 <result pre="patients152. In acutely ill patients admitted to hospital, confusion and" exact="delirium" post="could occur (reported in over 25% of COVID-19 hospitalized"/>
 <result pre="of underlying cognitive and behavioral symptoms, specifically anxiety153. Possibility of" exact="post-traumatic stress disorder" post="(PTSD) as observed in previous SARS and MERS pandemics38."/>
 <result pre="disorder (PTSD) as observed in previous SARS and MERS pandemics38." exact="Increased" post="levodopa requirement during acute admissions and need for non-oral"/>
 <result pre="in previous SARS and MERS pandemics38. Increased levodopa requirement during" exact="acute" post="admissions and need for non-oral dopaminergic therapies in some"/>
 <result pre="in-person consultations and admissions to hospital147. The impact of severe" exact="infection" post="(by default, implying a high viral load or a"/>
 <result pre="The impact of severe infection (by default, implying a high" exact="viral" post="load or a pro-inflammatory state) may lead to hospitalization"/>
 <result pre="on non-oral therapies (subcutaneous apomorphine, intrajejunal levodopa infusion, and deep" exact="brain" post="stimulation (DBS)) for advanced PD151. Limited observations from admission"/>
 <result pre="levodopa infusion, and deep brain stimulation (DBS)) for advanced PD151." exact="Limited" post="observations from admission of such cases around the world"/>
 <result pre="rates and may have an increased levodopa requirement during the" exact="acute" post="illness45,46. Pre-existing dyspnea of PD152,155, respiratory muscle bradykinesia155 in"/>
 <result pre="levodopa requirement during the acute illness45,46. Pre-existing dyspnea of PD152,155," exact="respiratory" post="muscle bradykinesia155 in addition to a possible direct SARS-CoV-2-related"/>
 <result pre="requirement during the acute illness45,46. Pre-existing dyspnea of PD152,155, respiratory" exact="muscle" post="bradykinesia155 in addition to a possible direct SARS-CoV-2-related brainstem-generated"/>
 <result pre="additional negative roles77,78,156,157. Fatigue has been commonly reported after many" exact="viral" post="infections, most notably with Epstein-Barr virus158, and is evident"/>
 <result pre="contributor of quality of life160. Myalgia is also common after" exact="viral" post="illnesses including COVID-1940,161, and in some cases of COVID-19"/>
 <result pre="cases went on to develop a PTSD with 15% developing" exact="depression" post="and anxiety at 1 year, and fatigue in more"/>
 <result pre="on to develop a PTSD with 15% developing depression and" exact="anxiety" post="at 1 year, and fatigue in more than 15%38."/>
 <result pre="well as subjects with other neurodegenerative disorders, such as Alzheimerâ€™s" exact="disease" post="or amyotrophic lateral sclerosis. Fig. 2 Flowchart identifying potential"/>
 <result pre="subjects with other neurodegenerative disorders, such as Alzheimerâ€™s disease or" exact="amyotrophic lateral sclerosis." post="Fig. 2 Flowchart identifying potential management issues in Parkinsonâ€™s"/>
 <result pre="with other neurodegenerative disorders, such as Alzheimerâ€™s disease or amyotrophic" exact="lateral sclerosis." post="Fig. 2 Flowchart identifying potential management issues in Parkinsonâ€™s"/>
 <result pre="sclerosis. Fig. 2 Flowchart identifying potential management issues in Parkinsonâ€™s" exact="disease" post="patients. a Parkinsonâ€™s disease patients exposed to self-isolation or"/>
 <result pre="identifying potential management issues in Parkinsonâ€™s disease patients. a Parkinsonâ€™s" exact="disease" post="patients exposed to self-isolation or b, c infection with"/>
 <result pre="a Parkinsonâ€™s disease patients exposed to self-isolation or b, c" exact="infection" post="with Coronavirus disease 2019 virus. Conclusions There has been"/>
 <result pre="patients exposed to self-isolation or b, c infection with Coronavirus" exact="disease" post="2019 virus. Conclusions There has been a large number"/>
 <result pre="to pre-existing conditions and in part to different modes of" exact="viral" post="entry and the presence of T cells that are"/>
 <result pre="manifestations may be related to inflammation involving capillaries and the" exact="blood-brain barrier," post="hypoxemia, and thrombosis acting as triggers for seizures or"/>
 <result pre="to inflammation involving capillaries and the blood-brain barrier, hypoxemia, and" exact="thrombosis" post="acting as triggers for seizures or leading to ischemic"/>
 <result pre="the blood-brain barrier, hypoxemia, and thrombosis acting as triggers for" exact="seizures" post="or leading to ischemic or hemorrhagic strokes. Neuropathology studies"/>
 <result pre="clearly answered the central issue of whether the virus enters" exact="central nervous system" post="neurons, astrocytes or microglia. In brain vasculature, the cell"/>
 <result pre="virus enters central nervous system neurons, astrocytes or microglia. In" exact="brain" post="vasculature, the cell types that express virus have not"/>
 <result pre="protein ACE2, which is thought to act as the major" exact="viral" post="receptor that enables viral entry. Such expression may, however,"/>
 <result pre="thought to act as the major viral receptor that enables" exact="viral" post="entry. Such expression may, however, be activated by inflammation,"/>
 <result pre="brains will be important. There is a variety of alternative" exact="viral" post="receptors for coronavirus, including sialic acid residues, that are"/>
 <result pre="and astrocytes. In contrast to the 1918 influenza pandemic and" exact="avian flu," post="reports of encephalopathy in COVID-19 have been slow to"/>
 <result pre="to the 1918 influenza pandemic and avian flu, reports of" exact="encephalopathy" post="in COVID-19 have been slow to emerge, and there"/>
 <result pre="are so far no documented reports of an induction of" exact="parkinsonism" post="apart from a single report. While a role for"/>
 <result pre="a role for the virus in causing or exacerbating Parkinsonâ€™s" exact="disease" post="appears unlikely at this time, the aggravation of specific"/>
 <result pre="He serves as consultant for Boehringerâ€&quot;Ingelheim for legal cases on" exact="pathological gambling," post="outside the submitted work. V.L., A.N., R.J.S., J.E.G., O.A.,"/>
 <result pre="D. M., Taubenberger, J. K. &amp;amp; Fauci, A. S. H7N9" exact="avian influenza" post="A virus and the perpetual challenge of potential human"/>
 <result pre="global burden of premature mortality due to the Middle East" exact="respiratory" post="syndrome (MERS) using standard expected years of life lost,"/>
 <result pre="burden of premature mortality due to the Middle East respiratory" exact="syndrome" post="(MERS) using standard expected years of life lost, 2012"/>
 <result pre="coronavirus that causes a global threatInt. J. Biol. Sci.2020161678168532226285 10.AstutiIYsrafilSevere" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral"/>
 <result pre="that causes a global threatInt. J. Biol. Sci.2020161678168532226285 10.AstutiIYsrafilSevere acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure"/>
 <result pre="causes a global threatInt. J. Biol. Sci.2020161678168532226285 10.AstutiIYsrafilSevere acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2): an overview of viral structure and"/>
 <result pre="10.AstutiIYsrafilSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of" exact="viral" post="structure and host responseDiabetes Metab. Syndr.20201440741232335367 11.ChenNet al.Epidemiological and"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751332007143 12.Grifoni, A. et"/>
 <result pre="T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19" exact="disease" post="and unexposed individuals. Cell.10.1016/j.cell.2020.05.015 (2020). 13.GuJHanBWangJCOVID-19: gastrointestinal manifestations and"/>
 <result pre="al.Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus" exact="disease" post="2019â€&quot;COVID-NET, 14 States, March 1â€&quot;30, 2020MMWR Morb. Moral. Wkly"/>
 <result pre="P. Understanding the cytokine storm during COVID-19: contribution of preexisting" exact="chronic" post="inflammation. Eur. J. Rheumatol.10.5152/eurjrheum.2020.2062 (2020). 21.GohKJet al.Rapid progression to"/>
 <result pre="chronic inflammation. Eur. J. Rheumatol.10.5152/eurjrheum.2020.2062 (2020). 21.GohKJet al.Rapid progression to" exact="acute" post="respiratory distress syndrome: review of current understanding of critical"/>
 <result pre="inflammation. Eur. J. Rheumatol.10.5152/eurjrheum.2020.2062 (2020). 21.GohKJet al.Rapid progression to acute" exact="respiratory" post="distress syndrome: review of current understanding of critical illness"/>
 <result pre="Med. Singap.20204910811832200400 22.Harenberg, J. &amp;amp; Favaloro, E. COVID-19: progression of" exact="disease" post="and intravascular coagulation - present status and future perspectives."/>
 <result pre="J., Iba, T. &amp;amp; Levy, J. H. Coagulation abnormalities and" exact="thrombosis" post="in patients with COVID-19. Lancet Haematol.10.1016/s2352-3026(20)30145-9 (2020). 24.Chiotos, K."/>
 <result pre="patients with COVID-19. Lancet Haematol.10.1016/s2352-3026(20)30145-9 (2020). 24.Chiotos, K. et al." exact="Multisystem" post="inflammatory syndrome in children during the COVID-19 pandemic: a"/>
 <result pre="COVID-19. Lancet Haematol.10.1016/s2352-3026(20)30145-9 (2020). 24.Chiotos, K. et al. Multisystem inflammatory" exact="syndrome" post="in children during the COVID-19 pandemic: a case series."/>
 <result pre="in children during the COVID-19 pandemic: a case series. J." exact="Pediatric" post="Infect. Dis. Soc.10.1093/jpids/piaa069 (2020). 25.Jose, R. J. &amp;amp; Manuel,"/>
 <result pre="and coagulation. Lancet Respir. Med.10.1016/s2213-2600(20)30216-2 (2020). 26.Mao, L. et al." exact="Neurologic" post="manifestations of hospitalized patients with coronavirus disease 2019 in"/>
 <result pre="L. et al. Neurologic manifestations of hospitalized patients with coronavirus" exact="disease" post="2019 in Wuhan, China. JAMA Neurol.10.1001/jamaneurol.2020.1127 (2020). 27.Esposito, G."/>
 <result pre="neuroinvasive potential of SARS-CoV2 may play a role in the" exact="respiratory" post="failure of COVID-19 patients. J. Med. Virol.10.1002/jmv.25728 (2020). 29.MoriguchiTet"/>
 <result pre="F., Moll, J., Munoz, D. P. &amp;amp; Ferreira, S. T." exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central"/>
 <result pre="Moll, J., Munoz, D. P. &amp;amp; Ferreira, S. T. Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous"/>
 <result pre="J., Munoz, D. P. &amp;amp; Ferreira, S. T. Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system."/>
 <result pre="Munoz, D. P. &amp;amp; Ferreira, S. T. Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends"/>
 <result pre="T. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the" exact="central nervous system." post="Trends Neurosci.10.1016/j.tins.2020.04.004 (2020). 31.Paniz-Mondolfi, A. et al. Central nervous"/>
 <result pre="central nervous system. Trends Neurosci.10.1016/j.tins.2020.04.004 (2020). 31.Paniz-Mondolfi, A. et al." exact="Central" post="nervous system involvement by severe acute respiratory syndrome coronavirus-2"/>
 <result pre="31.Paniz-Mondolfi, A. et al. Central nervous system involvement by severe" exact="acute" post="respiratory syndrome coronavirus-2 (SARS-CoV-2). J. Med. Virol. 10.1002/jmv.25915 (2020)."/>
 <result pre="A. et al. Central nervous system involvement by severe acute" exact="respiratory" post="syndrome coronavirus-2 (SARS-CoV-2). J. Med. Virol. 10.1002/jmv.25915 (2020). 32.Poyiadji,"/>
 <result pre="et al. Central nervous system involvement by severe acute respiratory" exact="syndrome" post="coronavirus-2 (SARS-CoV-2). J. Med. Virol. 10.1002/jmv.25915 (2020). 32.Poyiadji, N."/>
 <result pre="J. Med. Virol. 10.1002/jmv.25915 (2020). 32.Poyiadji, N. et al. COVID-19-associated" exact="acute" post="hemorrhagic necrotizing encephalopathy: CT and MRI Features. Radiology. 10.1148/radiol.2020201187"/>
 <result pre="Radiology. 10.1148/radiol.2020201187 (2020). 33.Beyrouti, R. et al. Characteristics of ischaemic" exact="stroke" post="associated with COVID-19. J. Neurol. Neurosurg. Psychiatry10.1136/jnnp-2020-323586 (2020). 34.Ebrille,"/>
 <result pre="and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus" exact="disease" post="2019. J. Intern. Med.10.1111/joim.13089 (2020). 36.KotfisKet al.COVID-19: ICU delirium"/>
 <result pre="coronavirus disease 2019. J. Intern. Med.10.1111/joim.13089 (2020). 36.KotfisKet al.COVID-19: ICU" exact="delirium" post="management during SARS-CoV-2 pandemicCrit. Care20202417632345343 37.Zanin, L. et al."/>
 <result pre="SARS-CoV-2 pandemicCrit. Care20202417632345343 37.Zanin, L. et al. SARS-CoV-2 can induce" exact="brain" post="and spine demyelinating lesions. Acta Neurochir. (Wien).10.1007/s00701-020-04374-x (2020). 38.Rogers,"/>
 <result pre="Care20202417632345343 37.Zanin, L. et al. SARS-CoV-2 can induce brain and" exact="spine" post="demyelinating lesions. Acta Neurochir. (Wien).10.1007/s00701-020-04374-x (2020). 38.Rogers, J. P."/>
 <result pre="37.Zanin, L. et al. SARS-CoV-2 can induce brain and spine" exact="demyelinating" post="lesions. Acta Neurochir. (Wien).10.1007/s00701-020-04374-x (2020). 38.Rogers, J. P. et"/>
 <result pre="COVID-19 pandemic. Lancet Psychiatry. 10.1016/S2215-0366(20)30203-0 (2020). 39.RÃ¡bano-SuÃ¡rez, P. et al." exact="Generalized" post="myoclonus in COVID-19. Neurology.10.1212/wnl.0000000000009829 (2020). 40.WangDet al.Clinical characteristics of"/>
 <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan, ChinaJAMA202032310611069 41.Toscano, G. et al. Guillain-BarrÃ© syndrome"/>
 <result pre="coronavirus-infected pneumonia in Wuhan, ChinaJAMA202032310611069 41.Toscano, G. et al. Guillain-BarrÃ©" exact="syndrome" post="associated with SARS-CoV-2. N. Engl. J. Med.10.1056/NEJMc2009191 (2020). 42.Dâ€™AmicoFBaumgartDCDaneseSPeyrin-BirouletLDiarrhea"/>
 <result pre="V., Teo, J. &amp;amp; Chaudhuri, K. R. Outcome of Parkinsonâ€™s" exact="disease" post="patients affected by COVID-19. Mov. Disord.10.1002/mds.28104 (2020). 46.Hainque, E.,"/>
 <result pre="Disord.10.1002/mds.28104 (2020). 46.Hainque, E., G., D. Rapid worsening in Parkinsonâ€™s" exact="disease" post="may hide COVID-19 infection. Parkinsonism Relat. Disord.10.1016/j.parkreldis.2020.05.008 (2020). 47.FazziniEFlemingJFahnSCerebrospinal"/>
 <result pre="D. Rapid worsening in Parkinsonâ€™s disease may hide COVID-19 infection." exact="Parkinsonism" post="Relat. Disord.10.1016/j.parkreldis.2020.05.008 (2020). 47.FazziniEFlemingJFahnSCerebrospinal fluid antibodies to coronavirus in"/>
 <result pre="coronavirus in patients with Parkinsonâ€™s diseaseMov. Disord.199271531581316552 48.ArabiYMet al.Severe neurologic" exact="syndrome" post="associated with Middle East respiratory syndrome corona virus (MERS-CoV)Infection20154349550125600929"/>
 <result pre="diseaseMov. Disord.199271531581316552 48.ArabiYMet al.Severe neurologic syndrome associated with Middle East" exact="respiratory" post="syndrome corona virus (MERS-CoV)Infection20154349550125600929 49.YehEACollinsACohenMEDuffnerPKFadenHDetection of coronavirus in the"/>
 <result pre="Disord.199271531581316552 48.ArabiYMet al.Severe neurologic syndrome associated with Middle East respiratory" exact="syndrome" post="corona virus (MERS-CoV)Infection20154349550125600929 49.YehEACollinsACohenMEDuffnerPKFadenHDetection of coronavirus in the central"/>
 <result pre="respiratory syndrome corona virus (MERS-CoV)Infection20154349550125600929 49.YehEACollinsACohenMEDuffnerPKFadenHDetection of coronavirus in the" exact="central nervous system" post="of a child with acute disseminated encephalomyelitisPediatrics2004113e73e7614702500 50.NilssonAEdnerNAlbertJTernhagAFatal encephalitis"/>
 <result pre="coronavirus in the central nervous system of a child with" exact="acute" post="disseminated encephalomyelitisPediatrics2004113e73e7614702500 50.NilssonAEdnerNAlbertJTernhagAFatal encephalitis associated with coronavirus OC43 in"/>
 <result pre="nervous system of a child with acute disseminated encephalomyelitisPediatrics2004113e73e7614702500 50.NilssonAEdnerNAlbertJTernhagAFatal" exact="encephalitis" post="associated with coronavirus OC43 in an immunocompromised childInfect. Dis."/>
 <result pre="Biophys. Acta2009179271472118760350 52.DourmashkinRRDunnGCastanoVMcCallSAEvidence for an enterovirus as the cause of" exact="encephalitis" post="lethargicaBMC Infect. Dis.20121213622715890 53.HoffmanLAVilenskyJAEncephalitis lethargica: 100 years after the"/>
 <result pre="gut-brain axis: is intestinal inflammation a silent driver of Parkinsonâ€™s" exact="disease" post="pathogenesis?NPJ Parkinsonâ€™s Dis.20173328649603 57.LiFStructure, function, and evolution of coronavirus"/>
 <result pre="and is blocked by a clinically proven protease inhibitorCell2020181271280.e27832142651 60.PerrottaFMateraMGCazzolaMBiancoASevere" exact="respiratory" post="SARS-CoV2 infection: Does ACE2 receptor matter?Respir. Med.202016810599632364961 61.Wang, Q."/>
 <result pre="infection: Does ACE2 receptor matter?Respir. Med.202016810599632364961 61.Wang, Q. et al." exact="Structural" post="and functional basis of SARS-CoV-2 entry by using human"/>
 <result pre="64.Fantini, J., Di Scala, C., Chahinian, H. &amp;amp; Yahi, N." exact="Structural" post="and molecular modelling studies reveal a new mechanism of"/>
 <result pre="SARS-CoV-2. bioRxiv. Preprint at 10.1101/2020.03.24.006197 (2020). 66.HeXet al.Temporal dynamics in" exact="viral" post="shedding and transmissibility of COVID-19Nat. Med20202667267510.1038/s41591-020-0869-532296168 67.RobsonBBioinformatics studies on"/>
 <result pre="&amp;amp; Asokan, A. Modulation of sialic acid dependence influences the" exact="central nervous system" post="transduction profile of adeno-associated viruses. J. Virol.10.1128/jvi.00332-19 (2019). 70.JeffersSAet"/>
 <result pre="Virol.10.1128/jvi.00332-19 (2019). 70.JeffersSAet al.CD209L (L-SIGN) is a receptor for severe" exact="acute" post="respiratory syndrome coronavirusProc. Natl Acad. Sci. USA2004101157481575315496474 71.DingYet al.Organ"/>
 <result pre="(2019). 70.JeffersSAet al.CD209L (L-SIGN) is a receptor for severe acute" exact="respiratory" post="syndrome coronavirusProc. Natl Acad. Sci. USA2004101157481575315496474 71.DingYet al.Organ distribution"/>
 <result pre="70.JeffersSAet al.CD209L (L-SIGN) is a receptor for severe acute respiratory" exact="syndrome" post="coronavirusProc. Natl Acad. Sci. USA2004101157481575315496474 71.DingYet al.Organ distribution of"/>
 <result pre="coronavirusProc. Natl Acad. Sci. USA2004101157481575315496474 71.DingYet al.Organ distribution of severe" exact="acute" post="respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients:"/>
 <result pre="Natl Acad. Sci. USA2004101157481575315496474 71.DingYet al.Organ distribution of severe acute" exact="respiratory" post="syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications"/>
 <result pre="Acad. Sci. USA2004101157481575315496474 71.DingYet al.Organ distribution of severe acute respiratory" exact="syndrome" post="(SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for"/>
 <result pre="for pathogenesis and virus transmission pathwaysJ. Pathol.200420362263015141376 72.GuJet al.Multiple organ" exact="infection" post="and the pathogenesis of SARS. JExp. Med.2005202415424 73.Puelles, V."/>
 <result pre="J. Med.10.1056/NEJMc2011400 (2020). 74.Wichmann, D. et al. Autopsy findings and" exact="venous thromboembolism" post="in patients with COVID-19. Ann. Intern. Med.10.7326/M20-2003 (2020) 75.Sepehrinezhad,"/>
 <result pre="Translational lessons from animal models. Eur. J. Neurol.10.1111/ene.14277 (2020). 77.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere" exact="acute" post="respiratory syndrome coronavirus infection causes neuronal death in the"/>
 <result pre="lessons from animal models. Eur. J. Neurol.10.1111/ene.14277 (2020). 77.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere acute" exact="respiratory" post="syndrome coronavirus infection causes neuronal death in the absence"/>
 <result pre="from animal models. Eur. J. Neurol.10.1111/ene.14277 (2020). 77.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere acute respiratory" exact="syndrome" post="coronavirus infection causes neuronal death in the absence of"/>
 <result pre="models. Eur. J. Neurol.10.1111/ene.14277 (2020). 77.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere acute respiratory syndrome coronavirus" exact="infection" post="causes neuronal death in the absence of encephalitis in"/>
 <result pre="J. Neurol.10.1111/ene.14277 (2020). 77.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere acute respiratory syndrome coronavirus infection causes" exact="neuronal" post="death in the absence of encephalitis in mice transgenic"/>
 <result pre="acute respiratory syndrome coronavirus infection causes neuronal death in the" exact="absence of" post="encephalitis in mice transgenic for human ACE2J. Virol.2008827264727518495771 78.LiKet"/>
 <result pre="syndrome coronavirus infection causes neuronal death in the absence of" exact="encephalitis" post="in mice transgenic for human ACE2J. Virol.2008827264727518495771 78.LiKet al.Middle"/>
 <result pre="in mice transgenic for human ACE2J. Virol.2008827264727518495771 78.LiKet al.Middle East" exact="respiratory" post="syndrome coronavirus causes multiple organ damage and lethal disease"/>
 <result pre="mice transgenic for human ACE2J. Virol.2008827264727518495771 78.LiKet al.Middle East respiratory" exact="syndrome" post="coronavirus causes multiple organ damage and lethal disease in"/>
 <result pre="East respiratory syndrome coronavirus causes multiple organ damage and lethal" exact="disease" post="in mice transgenic for human dipeptidyl peptidase 4J. Infect."/>
 <result pre="mice transgenic for human dipeptidyl peptidase 4J. Infect. Dis.201621371272226486634 79.LiYCBaiWZHiranoNHayashidaTHashikawaTCoronavirus" exact="infection" post="of rat dorsal root ganglia: ultrastructural characterization of viral"/>
 <result pre="79.LiYCBaiWZHiranoNHayashidaTHashikawaTCoronavirus infection of rat dorsal root ganglia: ultrastructural characterization of" exact="viral" post="replication, transfer, and the early response of satellite cellsVirus"/>
 <result pre="communicationJ. Comp. Neurol.201352120321222700307 81.AndriesKPensaertMBImmunofluorescence studies on the pathogenesis of hemagglutinating" exact="encephalomyelitis" post="virus infection in pigs after oronasal inoculationAm. J. Vet."/>
 <result pre="Comp. Neurol.201352120321222700307 81.AndriesKPensaertMBImmunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis" exact="virus infection" post="in pigs after oronasal inoculationAm. J. Vet. Res.198041137213786255837 82.ChaseyDAlexanderDJMorphogenesis"/>
 <result pre="Neurol.201352120321222700307 81.AndriesKPensaertMBImmunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis virus" exact="infection" post="in pigs after oronasal inoculationAm. J. Vet. Res.198041137213786255837 82.ChaseyDAlexanderDJMorphogenesis"/>
 <result pre="pigs after oronasal inoculationAm. J. Vet. Res.198041137213786255837 82.ChaseyDAlexanderDJMorphogenesis of avian" exact="infectious" post="bronchitis virus in primary chick kidney cellsArch. Virol.197652101111187144 83.PanWet"/>
 <result pre="after oronasal inoculationAm. J. Vet. Res.198041137213786255837 82.ChaseyDAlexanderDJMorphogenesis of avian infectious" exact="bronchitis" post="virus in primary chick kidney cellsArch. Virol.197652101111187144 83.PanWet al.Cytokine"/>
 <result pre="J. Vet. Res.198041137213786255837 82.ChaseyDAlexanderDJMorphogenesis of avian infectious bronchitis virus in" exact="primary" post="chick kidney cellsArch. Virol.197652101111187144 83.PanWet al.Cytokine signaling modulates blood-brain"/>
 <result pre="in primary chick kidney cellsArch. Virol.197652101111187144 83.PanWet al.Cytokine signaling modulates" exact="blood-brain barrier" post="functionCurr. Pharm. Des.2011173729374021834767 84.ObermeierBDanemanRRansohoffRMDevelopment, maintenance and disruption of the"/>
 <result pre="of the blood-brain barrierNat. Med.2013191584159624309662 85.MuldoonLLet al.Immunologic privilege in the" exact="central nervous system" post="and the blood-brain barrierJ. Cereb. Blood. Flow. Metab.201333132123072749 86.Pilotto,"/>
 <result pre="barrierJ. Cereb. Blood. Flow. Metab.201333132123072749 86.Pilotto, A. et al. Steroid-responsive" exact="encephalitis" post="in Covid-19 disease. Ann. Neurol. 10.1002/ana.25783 (2020). 87.TipnisSRet al.A"/>
 <result pre="step in understanding SARS pathogenesisJ. pathol.200420363163715141377 93.DoobayMFet al.Differential expression of" exact="neuronal" post="ACE2 in transgenic mice with overexpression of the brain"/>
 <result pre="of neuronal ACE2 in transgenic mice with overexpression of the" exact="brain" post="renin-angiotensin systemAm. J. Physiol. Regul. Integr. Comp. Physiol.2007292R373R38116946085 94.GowrisankarYVClarkMAAngiotensin"/>
 <result pre="94.GowrisankarYVClarkMAAngiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat" exact="primary" post="astrocyte culturesJ. Neurochem.2016138748527085714 95.XiaHLazartiguesEAngiotensin-converting enzyme 2: central regulator for"/>
 <result pre="primary astrocyte culturesJ. Neurochem.2016138748527085714 95.XiaHLazartiguesEAngiotensin-converting enzyme 2: central regulator for" exact="cardiovascular" post="functionCurr. Hypertens. Rep.20101217017520424953 96.XiaHSriramulaSChhabraKHLazartiguesEBrain angiotensin-converting enzyme type 2 shedding"/>
 <result pre="central regulator for cardiovascular functionCurr. Hypertens. Rep.20101217017520424953 96.XiaHSriramulaSChhabraKHLazartiguesEBrain angiotensin-converting enzyme" exact="type 2" post="shedding contributes to the development of neurogenic hypertensionCirc. res.20131131087109624014829"/>
 <result pre="of neurogenic hypertensionCirc. res.20131131087109624014829 97.MartinDXuJPorrettaCNicholsCDNeurocytometry: flow cytometric sorting of specific" exact="neuronal" post="populations from human and rodent brainACS Chem. Neurosci.2017835636728135061 98.ZhangRet"/>
 <result pre="in the regulation ACE and ACE2 expression in hypoxic human" exact="pulmonary" post="artery smooth muscle cellsAm. J. Physiol. Lung Cell Mol."/>
 <result pre="ACE and ACE2 expression in hypoxic human pulmonary artery smooth" exact="muscle" post="cellsAm. J. Physiol. Lung Cell Mol. Physiol.2009297L631L64019592460 99.Ziegler, C."/>
 <result pre="glutamate stimulation impairs ACE2 activity through ADAM17-mediated shedding in cultured" exact="cortical" post="neuronsCell Mol. Neurobiol.2018381235124329766392 101.Chen, R. et al. The spatial"/>
 <result pre="status associations with cell type-specific expression of mediators of SARS-CoV-2" exact="viral" post="entry and highlights inflammatory programs in putative target cells."/>
 <result pre="and neurodegeneration. Mov. Disord.10.1002/mds.28084 (2020). 105.Ezzat, K. et al. The" exact="viral" post="protein corona directs viral pathogenesis and amyloid aggregation. Nat."/>
 <result pre="(2020). 105.Ezzat, K. et al. The viral protein corona directs" exact="viral" post="pathogenesis and amyloid aggregation. Nat. Commun. 10, 2331 (2019)."/>
 <result pre="pathogenesis and amyloid aggregation. Nat. Commun. 10, 2331 (2019). 106.TulisiakCTMercadoGPeelaertsWBrundinLBrundinPCan" exact="infections" post="trigger alpha-synucleinopathies?Prog. Mol. Biol. Transl. Sci.201916829932231699323 107.MasseyARBeckhamJDAlpha-synuclein, a novel"/>
 <result pre="infections trigger alpha-synucleinopathies?Prog. Mol. Biol. Transl. Sci.201916829932231699323 107.MasseyARBeckhamJDAlpha-synuclein, a novel" exact="viral" post="restriction factor hiding in plain sightDNA Cell. Biol.20163564364527631132 108.Lechien,"/>
 <result pre="as a clinical presentation of mild-to-moderate forms of the coronavirus" exact="disease" post="(COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol.10.1007/s00405-020-05965-1 (2020)."/>
 <result pre="C. Clinical presentation of COVID-19: a systematic review focusing on" exact="upper" post="airway symptoms. Ear Nose Throat J.10.1177/0145561320920762 (2020). 115.PonsenMMet al.Idiopathic"/>
 <result pre="and altered mental status: a unique neurological manifestation of coronavirus" exact="disease" post="2019Cureus202012e786932489724 117.GuttmanMReceptors in the basal gangliaCan. J. Neurol. Sci.1987143954012824009"/>
 <result pre="117.GuttmanMReceptors in the basal gangliaCan. J. Neurol. Sci.1987143954012824009 118.GoldsteinDSDysautonomia in" exact="Parkinson" post="diseaseCompr. Physiol.2014480582624715569 119.MÃ©ndez-Guerrero, A. et al. Acute hypokinetic-rigid syndrome"/>
 <result pre="Sci.1987143954012824009 118.GoldsteinDSDysautonomia in Parkinson diseaseCompr. Physiol.2014480582624715569 119.MÃ©ndez-Guerrero, A. et al." exact="Acute" post="hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology.10.1212/wnl.0000000000010282 (2020). 120.Rodriguez-Perez, A."/>
 <result pre="in Parkinson diseaseCompr. Physiol.2014480582624715569 119.MÃ©ndez-Guerrero, A. et al. Acute hypokinetic-rigid" exact="syndrome" post="following SARS-CoV-2 infection. Neurology.10.1212/wnl.0000000000010282 (2020). 120.Rodriguez-Perez, A. I. et"/>
 <result pre="SARS-CoV-2 infection. Neurology.10.1212/wnl.0000000000010282 (2020). 120.Rodriguez-Perez, A. I. et al. Angiotensin" exact="type 2" post="receptors: Role in aging and neuroinflammation in the substantia"/>
 <result pre="et al. Angiotensin type 2 receptors: Role in aging and" exact="neuroinflammation" post="in the substantia nigra. Brain. Behav. Immun.10.1016/j.bbi.2019.12.011 (2019). 121.JoglarBet"/>
 <result pre="121.JoglarBet al.The inflammatory response in the MPTP model of Parkinsonâ€™s" exact="disease" post="is mediated by brain angiotensin: relevance to progression of"/>
 <result pre="in the MPTP model of Parkinsonâ€™s disease is mediated by" exact="brain" post="angiotensin: relevance to progression of the diseaseJ. Neurochem.200910965666919245663 122.GarrettiFAgalliuDLindestam"/>
 <result pre="mechanismsNat. Rev. Neurosci.20078576917180163 125.WilliamsGPet al.T cell infiltration in both human" exact="multiple system atrophy" post="and a novel mouse model of the diseaseActa Neuropathol.202013985587431993745"/>
 <result pre="Neurosci.20078576917180163 125.WilliamsGPet al.T cell infiltration in both human multiple system" exact="atrophy" post="and a novel mouse model of the diseaseActa Neuropathol.202013985587431993745"/>
 <result pre="model of the diseaseActa Neuropathol.202013985587431993745 126.LodyginDet al.Î²-Synuclein-reactive T cells induce" exact="autoimmune" post="CNS grey matter degenerationNature201956650350830787438 127.GagneJJPowerMCAnti-inflammatory drugs and risk of"/>
 <result pre="autoimmune CNS grey matter degenerationNature201956650350830787438 127.GagneJJPowerMCAnti-inflammatory drugs and risk of" exact="Parkinson" post="disease: a meta-analysisNeurology201074995100220308684 128.JangHet al.Highly pathogenic H5N1 influenza virus"/>
 <result pre="meta-analysisNeurology201074995100220308684 128.JangHet al.Highly pathogenic H5N1 influenza virus can enter the" exact="central nervous system" post="and induce neuroinflammation and neurodegenerationProc. Natl Acad. Sci. USA2009106140631406819667183"/>
 <result pre="influenza virus can enter the central nervous system and induce" exact="neuroinflammation" post="and neurodegenerationProc. Natl Acad. Sci. USA2009106140631406819667183 129.JangHet al.Inflammatory effects"/>
 <result pre="Sci. USA2009106140631406819667183 129.JangHet al.Inflammatory effects of highly pathogenic H5N1 influenza" exact="virus infection" post="in the CNS of miceJ. Neurosci.2012321545155922302798 130.BantleCMet al.Infection with"/>
 <result pre="USA2009106140631406819667183 129.JangHet al.Inflammatory effects of highly pathogenic H5N1 influenza virus" exact="infection" post="in the CNS of miceJ. Neurosci.2012321545155922302798 130.BantleCMet al.Infection with"/>
 <result pre="al.Infection with mosquito-borne alphavirus induces selective loss of dopaminergic neurons," exact="neuroinflammation" post="and widespread protein aggregationNPJ Parkinsons Dis.201952031531390 131.KobasaDet al.Enhanced virulence"/>
 <result pre="1918 pandemic virusNature200443170370715470432 132.KobasaDet al.Aberrant innate immune response in lethal" exact="infection" post="of macaques with the 1918 influenza virusNature200744531932317230189 133.MiyamotoKet al.Systemic"/>
 <result pre="macaques with the 1918 influenza virusNature200744531932317230189 133.MiyamotoKet al.Systemic inflammatory response" exact="syndrome" post="and prolonged hypoperfusion lesions in an infant with respiratory"/>
 <result pre="response syndrome and prolonged hypoperfusion lesions in an infant with" exact="respiratory" post="syncytial virus encephalopathyJ. Infect. Chemother.20131997898223354937 134.Sadasivan, S., Sharp, B.,"/>
 <result pre="T cell memory to influenza virusesPLoS ONE201510e012976826086392 138.VargaZet al.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19Lancet20203951417141832325026 139.BartonLMDuvalEJStrobergEGhoshSMukhopadhyaySCOVID-19 autopsies, Oklahoma, USAAm. J."/>
 <result pre="J. Clin. Pathol.202015372573332275742 140.XuZet al.Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndromeLancet Respir. Med.2020842042232085846 141.TianSet al.Pulmonary pathology of"/>
 <result pre="Clin. Pathol.202015372573332275742 140.XuZet al.Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndromeLancet Respir. Med.2020842042232085846 141.TianSet al.Pulmonary pathology of early-phase"/>
 <result pre="Med.2020842042232085846 141.TianSet al.Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="in two patients with lung cancerJ. Thorac. Oncol.20201570070432114094 142.Adachi,"/>
 <result pre="143.Menter, T. et al. Post-mortem examination of COVID19 patients reveals" exact="diffuse" post="alveolar damage with severe capillary congestion and variegated findings"/>
 <result pre="congestion and variegated findings of lungs and other organs suggesting" exact="vascular" post="dysfunction. Histopathology.10.1111/his.14134 (2020). 144.Cilia, R. et al. Effects of"/>
 <result pre="(2020). 144.Cilia, R. et al. Effects of COVID-19 on Parkinsonâ€™s" exact="disease" post="clinical features: a community-based case-control study. Mov. Disord.10.1002/mds.28170 (2020)."/>
 <result pre="Mov. Disord.10.1002/mds.28170 (2020). 145.Fasano, A. et al. COVID-19 in Parkinsonâ€™s" exact="disease" post="patients living in Lombardy, Italy. Mov. Disord.10.1002/mds.28176 (2020). 146.Papa,"/>
 <result pre="M. et al. Impact of the COVID-19 pandemic on Parkinsonâ€™s" exact="disease" post="and movement disorders. Mov. Disord.10.1002/mds.28067 (2020). 147.StoesslAJBhatiaKPMerelloMMovement disorders in"/>
 <result pre="al. Impact of the COVID-19 pandemic on Parkinsonâ€™s disease and" exact="movement disorders." post="Mov. Disord.10.1002/mds.28067 (2020). 147.StoesslAJBhatiaKPMerelloMMovement disorders in the world of"/>
 <result pre="early review of its global impact and considerations for Parkinsonâ€™s" exact="Disease" post="Patient Care. J. Mov. Disord.10.14802/jmd.20042 (2020). 149.Schirinzi, T. et"/>
 <result pre="149.Schirinzi, T. et al. Self-reported needs of patients with Parkinsonâ€™s" exact="disease" post="during COVID-19 emergency in Italy. Neurol. Sci.10.1007/s10072-020-04442-1 (2020). 150.TiptonPWWszolekZKWhat"/>
 <result pre="COVID-19 emergency in Italy. Neurol. Sci.10.1007/s10072-020-04442-1 (2020). 150.TiptonPWWszolekZKWhat can Parkinsonâ€™s" exact="disease" post="teach us about COVID-19?Neurol. Neurochir. Pol.20205420420632323862 151.FasanoAet al.Management of"/>
 <result pre="COVID-19?Neurol. Neurochir. Pol.20205420420632323862 151.FasanoAet al.Management of advanced therapies in Parkinsonâ€™s" exact="disease" post="patients in times of humanitarian crisis: the COVID-19 experienceMov."/>
 <result pre="in Parkinsonâ€™s diseaseParkinsonism Relat. Disord.20196016216630224267 153.Prasad, S. et al. Parkinsonâ€™s" exact="Disease" post="and COVID-19: perceptions and implications in patients and caregivers."/>
 <result pre="dysfunction in Parkinsonâ€™s diseaseJ. R. Coll. Physicians Edinb.201747353928569280 156.McCrayPBJr.et al.Lethal" exact="infection" post="of K18-hACE2 mice infected with severe acute respiratory syndrome"/>
 <result pre="Edinb.201747353928569280 156.McCrayPBJr.et al.Lethal infection of K18-hACE2 mice infected with severe" exact="acute" post="respiratory syndrome coronavirusJ. Virol.20078181382117079315 157.MatsudaKet al.The vagus nerve is"/>
 <result pre="156.McCrayPBJr.et al.Lethal infection of K18-hACE2 mice infected with severe acute" exact="respiratory" post="syndrome coronavirusJ. Virol.20078181382117079315 157.MatsudaKet al.The vagus nerve is one"/>
 <result pre="al.Lethal infection of K18-hACE2 mice infected with severe acute respiratory" exact="syndrome" post="coronavirusJ. Virol.20078181382117079315 157.MatsudaKet al.The vagus nerve is one route"/>
 <result pre="with severe acute respiratory syndrome coronavirusJ. Virol.20078181382117079315 157.MatsudaKet al.The vagus" exact="nerve" post="is one route of transneural invasion for intranasally inoculated"/>
 <result pre="influenza a virus in miceVet. Pathol.20044110110715017022 158.JonesJFEpstein-Barr virus and the" exact="chronic" post="fatigue syndrome: a short reviewMicrobiol. Sci.198853663692856301 159.GuanWJet al.Clinical characteristics"/>
 <result pre="miceVet. Pathol.20044110110715017022 158.JonesJFEpstein-Barr virus and the chronic fatigue syndrome: a" exact="short" post="reviewMicrobiol. Sci.198853663692856301 159.GuanWJet al.Clinical characteristics of coronavirus disease 2019"/>
 <result pre="syndrome: a short reviewMicrobiol. Sci.198853663692856301 159.GuanWJet al.Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaN. Engl. J. Med.20203821708172032109013 160.Lazcano-OcampoCet al.Identifying and"/>
</results>
